First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study (Q38536391)
Jump to navigation
Jump to search
scientific article published on 23 June 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study |
scientific article published on 23 June 2015 |
Statements
1 reference
First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study (English)
1 reference
F Xia
1 reference
Y-L Wu
1 reference
C Zhou
1 reference
C-K Liam
1 reference
G Wu
1 reference
X Liu
1 reference
Z Zhong
1 reference
S Lu
1 reference
Y Cheng
1 reference
B Han
1 reference
L Chen
1 reference
C Huang
1 reference
S Qin
1 reference
Y Zhu
1 reference
H Pan
1 reference
H Liang
1 reference
E Li
1 reference
G Jiang
1 reference
S H How
1 reference
M C L Fernando
1 reference
Y Zhang
1 reference
Y Zuo
1 reference
23 June 2015
1 reference
1 reference
26
1 reference
9
1 reference
1883-1889
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference